Stifel Financial Corp Tff Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.84 - $100.75 $3,780 - $453,375	-4,500 Reduced 18.6%	19,700 $20,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $4,149 - $104,400	-900 Reduced 3.59%	24,200 $98,000
Q2 2022 Aug 15, 2022	BUY	$3.99 - $7.22 $14,364 - $25,992	3,600 Added 16.74%	25,100 $142,000
Q1 2022 May 13, 2022	BUY	$5.28 - $9.17 $36,960 - $64,190	7,000 Added 48.28%	21,500 $136,000
Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $24,010 - $33,775	3,500 Added 31.82%	14,500 $129,000
Q3 2021 Nov 15, 2021	SELL	$7.21 - $10.49 $18,025 - $26,225	-2,500 Reduced 18.52%	11,000 $85,000
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $4,240 - $6,805	500 Added 3.85%	13,500 $130,000
Q1 2021 May 14, 2021	BUY	$12.96 - $19.75 $168,480 - $256,750	13,000 New	13,000 $176,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.